DNA Funded vs TakeProfitTrader (2026) — Which Is Better?

At-a-Glance Match-Up

DNA Funded targets multi-asset traders seeking regulated, low-cost evaluation with broker backing, while TakeProfitTrader focuses exclusively on futures traders who value unlimited daily withdrawals and lenient drawdown rules. DNA Funded operates through TradeLocker with 800+ CFD instruments across forex, commodities, and indices; TakeProfitTrader runs on Tradovate and accepts only futures contracts. Both offer no-time-limit challenges, but they serve fundamentally different trading ecosystems and risk tolerances.

Price Reality

DNA Funded charges a flat $49 per month for all challenge types (1-Phase, 2-Phase, Rapid, Instant Funding), with challenge fees ranging from $99–$299 depending on the phase. The critical advantage here is the fee-refund-on-first-payout policy: traders recover their initial challenge cost once they reach profitability. TakeProfitTrader's single-tier structure costs $90 monthly with account sizes of $25K ($99 initial), $50K ($199), $75K ($299), or $150K ($399). Over a 12-month period, DNA Funded's base cost is $588 plus a one-time challenge fee ($99–$299); TakeProfitTrader costs $1,080 plus the account purchase fee. DNA Funded wins on raw cost, but TakeProfitTrader's pricing includes access to simulated accounts, whereas DNA Funded charges separately for challenge evaluations. For a trader taking three DNA Funded challenges annually, costs would approach $1,500–$1,700; TakeProfitTrader users committed to one simulated account over 12 months pay approximately $1,170–$1,500. Neither offers a free trial—both require upfront payment.

The Toolkit

Profit Splits & Payouts: TakeProfitTrader's 90% split on PRO+ accounts outperforms DNA Funded's 80% maximum, and critically, TakeProfitTrader enables daily withdrawals with zero caps on withdrawal amounts. DNA Funded's challenge-based model means withdrawal frequency depends on completing phases and reaching profit targets. A trader generating $1,000 daily profit on TakeProfitTrader can extract that daily; on DNA Funded, withdrawal timing hinges on challenge progression. Winner: TakeProfitTrader for active income, DNA Funded for disciplined savers.

Asset Variety: DNA Funded's 800+ CFD instruments across forex, commodities, indices, and shares provide flexibility absent from TakeProfitTrader. A trader strategy-testing across ES, NQ, and MES contracts on TakeProfitTrader cannot simultaneously evaluate gold or forex pairs. DNA Funded restrictions exist (crypto excluded from Rapid; options/futures unavailable), but the breadth is substantially wider. Winner: DNA Funded.

Drawdown Rules & Risk Management: TakeProfitTrader eliminated daily loss limits in January 2025, replacing them with a single trailing max drawdown rule—a trader can lose $3,000 in one session if drawdown tolerance permits. DNA Funded's challenge structure enforces session-to-session accountability via time limits on 1-Phase and 2-Phase challenges. For risk-averse traders, DNA Funded's structure prevents outsized single-session losses; for experienced futures traders, TakeProfitTrader's simplified trailing drawdown feels liberating. Winner: Depends on risk profile.

Evaluation Speed & Accessibility: TakeProfitTrader's one-step evaluation and 6% profit target allow entry within 48 hours of signup; DNA Funded's instant-funding option accelerates this to near-immediate evaluation, but traders must pay the full challenge fee upfront without a "trial" phase. TakeProfitTrader's 50% consistency rule (50% of days must be profitable) enforces discipline; DNA Funded's time-unlimited challenges appeal to traders building long-term track records. Winner: TakeProfitTrader for speed, DNA Funded for flexibility.

Broker Regulation & Credibility: DNA Funded is backed by DNA Markets, an ASIC-regulated Australian broker—a rarity among prop firms and a material credibility marker. TakeProfitTrader uses Tradovate (regulated NFA/CFTC futures broker) but doesn't market this as a primary differentiator. For traders prioritizing regulatory oversight, DNA Funded's ASIC backing provides reassurance. Winner: DNA Funded.

Trustworthiness & Community Validation: TakeProfitTrader's Trustpilot score of 4.4/5 from 8,300+ reviews with 81% five-star ratings is exceptional and publicly visible. DNA Funded, founded in 2024, lacks this historical reputation depth—online reviews are sparse. For traders risk-averse about losing funds, TakeProfitTrader's transparent review density is a compelling asset. Winner: TakeProfitTrader.

Who Should Choose DNA Funded

- Multi-asset day traders (forex, commodities, indices, shares): If your strategy spans ES futures and gold, DNA Funded's 800+ instruments let you backtest and trade all on one platform without switching brokers.

- New traders building equity-account experience: 1-Phase and 2-Phase challenges with no time limits allow deliberate skill-building without the pressure of a 6% single-shot profit target.

- Traders in regions preferring ASIC oversight: If regulatory credibility matters (e.g., traders in Australia, Southeast Asia), ASIC backing from DNA Markets is a structural advantage over unregulated prop platforms.

- Traders recovering challenge fees: The refund-on-first-payout mechanic is rare and reduces the sting of failed evaluations for persistent traders willing to retry after closing small losses.

Who Should Choose TakeProfitTrader

- Professional futures traders seeking daily income: The daily payout mechanism with zero withdrawal caps is purpose-built for traders deriving income from prop trading, not capital accumulation.

- Scalpers and short-duration strategy traders: Elimination of daily loss limits and reliance on trailing drawdown instead lets intraday traders execute aggressive entries within a session without triggering daily halt rules.

- Traders valuing transparent, large-scale social proof: 8,300+ Trustpilot reviews provide statistically significant validation that payouts occur and platform mechanics work as advertised.

- Futures specialists: If your only strategy is ES, MES, NQ, or other futures contracts, TakeProfitTrader's single-asset focus means no feature bloat and alignment with your entire workflow (Tradovate is standard for futures traders).

Where This Leaves You

DNA Funded wins for multi-asset traders, cost-conscious evaluators, and anyone prioritizing regulatory backing; TakeProfitTrader wins for futures-focused traders, active-income seekers, and traders who value proven community trust at a 4.4/5 scale. DNA Funded's $49 monthly base is less than half TakeProfitTrader's $90, but TakeProfitTrader's daily payouts and 90% splits meaningfully exceed DNA Funded's 80% splits if monthly profit targets are met. Choose DNA Funded if you trade multiple asset classes or want flexibility in challenge structure; choose TakeProfitTrader if you trade only futures and need reliable daily withdrawals backed by thousands of verified reviews.